Cibc Private Wealth Group, LLC Clearside Biomedical, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $50.1 Billion
- Q1 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,100 shares of CLSD stock, worth $1,287. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,100Holding current value
$1,287% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLSD
# of Institutions
55Shares Held
15.4MCall Options Held
22.7KPut Options Held
200-
Armistice Capital, LLC New York, NY3.96MShares$4.63 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$2.91 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$2.57 Million3.43% of portfolio
-
Carmignac Gestion Paris, I02.13MShares$2.5 Million0.05% of portfolio
-
Black Rock Inc. New York, NY758KShares$887,1240.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $70.4M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...